Valeant Offers to Buy Allergan With Pershing's Support
Dr. Keith A. Marcus injects Allergan Inc. Botox between a patient's eyes at the offices of Marcus Facial Plastic Surgery in Redondo Beach, California, U.S., on Tuesday, April 22, 2014. Valeant Pharmaceuticals International Inc. offered to buy Allergan Inc., maker of the Botox wrinkle treatment, in a cash-and-stock deal valued at $45.7 billion in the latest step of the Canadian company's plan to become one of the world's largest drugmakers. Photographer: Patrick T. Fallon/Bloomberg via Getty Images
PURCHASE A LICENCE
How can I use this image?
£275.00
GBP
Getty ImagesValeant Offers to Buy Allergan With Pershing's Support, News Photo
Valeant Offers to Buy Allergan With Pershing's Support Get premium, high resolution news photos at Getty ImagesProduct #:486159831
Valeant Offers to Buy Allergan With Pershing's Support Get premium, high resolution news photos at Getty ImagesProduct #:486159831£375£150
Getty Images
In stockDETAILS
Restrictions:
Contact your local office for all commercial or promotional uses.For editorial use only. Additional clearance required for commercial or promotional use, contact your local office for assistance. Any commercial or promotional use of Bloomberg content requires Bloomberg's prior written consent.
Credit:
Editorial #:
486159831
Collection:
Bloomberg
Date created:
22 April, 2014
Upload date:
Licence type:
Release info:
Not released. More information
Source:
Bloomberg
Object name:
VALEANT ALLERGAN
Max file size:
4000 x 2667 px (33.87 x 22.58 cm) - 300 dpi - 3 MB